Biorez is a New Haven, Conn.-based medical device company advancing tendon and ligament repair. Led by President and CEO Kevin Rocco, the company developed the BioBrace implant, a porous collagen sponge reinforced with bioresorbable microfilaments. The BioBrace is intended to augment and reinforce a wide range of tendon and ligament procedures, including rotator cuff repair and ACL reconstruction. The products remain in the development stage and have not been approved by any regulatory agency, including the U.S. Food and Drug Administration. In September 2020 the company closed out $7.0M in seed financing, reflecting its current early-stage financing status. Soft Tissue Regeneration develops bioresorbable, implantable scaffolds and related devices for tendon and ligament repair, including the L-C Ligament® for ACL repair and regeneration. The company also markets STR GRAFT™, which received FDA 510(k) clearance in November 2012 for soft tissue augmentation and repair, and is developing a 3D braided surgical mesh for breast reconstruction and hernia repair. Founded in 2008 by Cato T. Laurencin, M.D., Ph.D., and Joseph Reilly, the company is based in New Haven, Connecticut. STR intends to use recent financing to complete a European Phase I clinical study and to advance the FDA regulatory process for L-C Ligament. Management includes president and CEO Joseph Reilly; three new board members joined following the financing.

Total raised

$9M

Funding rounds

2

Latest round

Seed

Latest activity

Sep 2020